The ILAILL Study: Iloprost as Adjuvant to Surgery for Acute Ischemia of Lower Limbs

Abstract

Although at lower levels than previously reported, our results confirm the severity of ALI. Iloprost as adjuvant to surgery significantly reduced mortality and overall major event rate. Further data are needed to support this finding, and to face a still open medical issue.